Activating the GP130 protein slows prostate cancer growth and enhances immune response, offering a potential treatment for aggressive cases. An international research team, led by Umeå University in Sweden, has demonstrated that a special protein could be pivotal in combating certain types of prostate cancer. Traditionally, treatments have focused on blocking this protein, which is […]
Source link
